These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9533534

  • 21. Hepatocyte growth factor profile with breast cancer.
    El-Attar HA, Sheta MI.
    Indian J Pathol Microbiol; 2011; 54(3):509-13. PubMed ID: 21934211
    [Abstract] [Full Text] [Related]

  • 22. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F, Wu L, Zheng S, Ding W, Teng L, Wang Z, Ma Z, Zhao W.
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [Abstract] [Full Text] [Related]

  • 23. Elevated preoperative serum ICTP is a prognostic factor for overall and disease-free survival in breast cancer.
    Keskikuru R, Bloigu R, Risteli J, Kataja V, Jukkola A.
    Oncol Rep; 2002 Jul; 9(6):1323-7. PubMed ID: 12375042
    [Abstract] [Full Text] [Related]

  • 24. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.
    Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG, Klijn JG.
    Cancer Res; 2001 Jul 15; 61(14):5407-14. PubMed ID: 11454684
    [Abstract] [Full Text] [Related]

  • 25. Preoperative CA 15-3 concentrations predict outcome of patients with breast carcinoma.
    Shering SG, Sherry F, McDermott EW, O'Higgins NJ, Duffy MJ.
    Cancer; 1998 Dec 15; 83(12):2521-7. PubMed ID: 9874458
    [Abstract] [Full Text] [Related]

  • 26. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma.
    Bièche I, Lazar V, Noguès C, Poynard T, Giovangrandi Y, Bellet D, Lidereau R, Vidaud M.
    Clin Cancer Res; 1998 Mar 15; 4(3):671-6. PubMed ID: 9533536
    [Abstract] [Full Text] [Related]

  • 27. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
    Silva JM, Silva J, Sanchez A, Garcia JM, Dominguez G, Provencio M, Sanfrutos L, Jareño E, Colas A, España P, Bonilla F.
    Clin Cancer Res; 2002 Dec 15; 8(12):3761-6. PubMed ID: 12473587
    [Abstract] [Full Text] [Related]

  • 28. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS, Wu TL, Tsao KC, Sun CF.
    Ann Clin Lab Sci; 2006 Dec 15; 36(1):23-30. PubMed ID: 16501233
    [Abstract] [Full Text] [Related]

  • 29. Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma.
    Talvensaari-Mattila A, Turpeenniemi-Hujanen T.
    Cancer Lett; 2005 Jan 20; 217(2):237-42. PubMed ID: 15617842
    [Abstract] [Full Text] [Related]

  • 30. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A, Olivotto IA.
    J Am Coll Surg; 2005 Jun 20; 200(6):912-21. PubMed ID: 15922205
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S, Masuda Y, Kurizaki T, Haga Y, Murayama T, Ikei S, Kamei M, Takeno S, Kawahara K.
    Anticancer Res; 2007 Jun 20; 27(4C):2803-8. PubMed ID: 17695451
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T, Nakada H, Yokoyama M, Matsuki M, Kato H, Kuwano H, Ishida H.
    Jpn J Clin Oncol; 2008 Dec 20; 38(12):839-43. PubMed ID: 18923001
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar 20; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

  • 40. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
    Okegawa T, Kinjo M, Nutahara K, Higashihara E.
    Int J Urol; 2006 Sep 20; 13(9):1197-201. PubMed ID: 16984552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.